Onyx Healthcare Inc., a professional medical IT company, provides medical PC solutions for the hospital/clinical IT market worldwide.
Share Price & News
How has Onyx Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 6569 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 6569's weekly volatility (4%) has been stable over the past year.
7 Day Return
TW Healthcare Services
1 Year Return
TW Healthcare Services
Return vs Industry: 6569 underperformed the TW Healthcare Services industry which returned -3.1% over the past year.
Return vs Market: 6569 underperformed the TW Market which returned 36.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Onyx Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 months ago | Simply Wall StHere's How We Evaluate Onyx Healthcare Inc.'s (GTSM:6569) Dividend
5 months ago | Simply Wall StReturns On Capital At Onyx Healthcare (GTSM:6569) Paint A Concerning Picture
6 months ago | Simply Wall StShareholders Of Onyx Healthcare (GTSM:6569) Must Be Happy With Their 46% Return
Onyx Healthcare Fundamentals Summary
|6569 fundamental statistics|
Is 6569 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|6569 income statement (TTM)|
|Cost of Revenue||NT$849.63m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||4.73|
|Net Profit Margin||11.41%|
How did 6569 perform over the long term?See historical performance and comparison
4.7%Current Dividend Yield
Is Onyx Healthcare undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 6569 (NT$107.5) is trading above our estimate of fair value (NT$96.9)
Significantly Below Fair Value: 6569 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 6569 is good value based on its PE Ratio (22.8x) compared to the Asian Healthcare Services industry average (51.6x).
PE vs Market: 6569 is poor value based on its PE Ratio (22.8x) compared to the TW market (16.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6569's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6569 is good value based on its PB Ratio (3.5x) compared to the XA Healthcare Services industry average (4.8x).
How is Onyx Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Onyx Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Onyx Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6569 has a high level of non-cash earnings.
Growing Profit Margin: 6569's current net profit margins (11.4%) are lower than last year (11.6%).
Past Earnings Growth Analysis
Earnings Trend: 6569's earnings have grown by 5.4% per year over the past 5 years.
Accelerating Growth: 6569's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6569 had negative earnings growth (-2.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (59.3%).
Return on Equity
High ROE: 6569's Return on Equity (15.1%) is considered low.
How is Onyx Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: 6569's short term assets (NT$696.8M) exceed its short term liabilities (NT$449.6M).
Long Term Liabilities: 6569's short term assets (NT$696.8M) exceed its long term liabilities (NT$247.3M).
Debt to Equity History and Analysis
Debt Level: 6569's debt to equity ratio (25.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6569's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6569's debt is well covered by operating cash flow (89.6%).
Interest Coverage: 6569 earns more interest than it pays, so coverage of interest payments is not a concern.
What is Onyx Healthcare current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6569's dividend (4.65%) is higher than the bottom 25% of dividend payers in the TW market (1.93%).
High Dividend: 6569's dividend (4.65%) is low compared to the top 25% of dividend payers in the TW market (5.25%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, 6569 has been paying a dividend for less than 10 years.
Growing Dividend: 6569's dividend payments have increased, but the company has only paid a dividend for 5 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (105.8%), 6569's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Yung-Shun Chuang has been Independent Director at Taiflex Scientific Co., Ltd. since July 16, 2021. Mr. Chuang is Representative Chairman of the Board of Directors of Onyx Healthcare Inc. since May 29,...
Experienced Management: 6569's management team is seasoned and experienced (7.8 years average tenure).
Experienced Board: 6569's board of directors are considered experienced (5.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Onyx Healthcare Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Onyx Healthcare Inc.
- Ticker: 6569
- Exchange: TPEX
- Founded: 2010
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: NT$3.253b
- Shares outstanding: 30.26m
- Website: https://www.onyx-healthcare.com
Number of Employees
- Onyx Healthcare Inc.
- No.135, Lane 235
- 2nd Floor
- New Taipei City
Onyx Healthcare Inc., a professional medical IT company, provides medical PC solutions for the hospital/clinical IT market worldwide. It offers mobile cart computers, ubiquitous power solutions, remote man...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 15:23|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.